Catalan medtech Aortyx closes €15M Series A for aortic tear patch
What's the deal? Barcelona-based medtech Aortyx has raised more than €15 million in a Series A round led by Ship2B VenturesDealroom has a profile for this one. Try Dealroom → and Clave CapitalDealroom has a profile for this one. Try Dealroom →, with the EIC Fund, CDTI InnvierteDealroom has a profile for this one. Try Dealroom →, Nara CapitalDealroom has a profile for this one. Try Dealroom →, and Catalan public investor Avançsa also participating.
The company is developing a catheter-delivered, bioabsorbable patch to treat aortic dissection — a tear in the aorta's wall. Its AX-GEN01 device measures 30mm and adheres to the vessel wall to seal the tear, a less invasive alternative to open surgery or conventional stents.
Where it goes: Proceeds will fund Aortyx's push toward its first in-human clinical trial. Founded in 2018 by researchers from the Institut Químic de Sarrià and Hospital Clínic de Barcelona, the company plans to grow to roughly 30 employees by 2028, adding staff in regulatory, quality, clinical, manufacturing, and finance roles.
The public angle: Avançsa, the Generalitat de Catalunya's industrial investment arm, put in €1.5 million for a 7.52% stake. Chief executive Clàudia Canals said entering the capital lets Avançsa back the company at "a decisive stage, that of clinical validation," while keeping the technology's value in Catalonia. (Translated from Spanish.)
Avançsa typically invests as a minority co-investor in revenue-stage Catalan companies; its portfolio includes INBRAIN Neuroelectronics and Open Cosmos.
What could go wrong? The technology remains at the development stage, with clinical validation still ahead. The round funds a high-risk milestone rather than a treatment ready for patients.
The signal: The round adds public-sector conviction to a Catalan deep tech story, pairing international venture backers with government money to carry a homegrown medical device toward its first clinical test.
Read more: capital-riesgo.es
Image credit: Aortyx
